The incorporation of butyl-methoxydibenzoylmethane (BMDBM), one of the most efficient and frequently used UV-A blockers, into lipospheres was examined in order to decrease the light-induced sunscreen degradation. Lipospheres, obtained by the melt technique and using tristearin as the lipid material and hydrogenated phosphatidylcholine as the emulsifier, showed proper features in terms of size (1040 mu m), BMDBM loading level (21.63% +/- 0.90%, w/w) and physical state. Photolysis studies, involving irradiation of lipospheres with simulated sunlight before and after their introduction in emulsion formulations, demonstrated a relevant enhancement of the encapsulated sunscreen photostability in comparison with unencapsulated BMDBM.

Influence of liposphere preparation on butyl-methoxydibenzoylmethane photostability / Iannuccelli, Valentina; Sala, Nicoletta; R., Tursilli; Coppi, Gilberto; S., Scalia. - In: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. - ISSN 0939-6411. - STAMPA. - 63:2(2006), pp. 140-145. [10.1016/j.ejpb.2006.01.007]

Influence of liposphere preparation on butyl-methoxydibenzoylmethane photostability

IANNUCCELLI, Valentina;SALA, Nicoletta;COPPI, Gilberto;
2006

Abstract

The incorporation of butyl-methoxydibenzoylmethane (BMDBM), one of the most efficient and frequently used UV-A blockers, into lipospheres was examined in order to decrease the light-induced sunscreen degradation. Lipospheres, obtained by the melt technique and using tristearin as the lipid material and hydrogenated phosphatidylcholine as the emulsifier, showed proper features in terms of size (1040 mu m), BMDBM loading level (21.63% +/- 0.90%, w/w) and physical state. Photolysis studies, involving irradiation of lipospheres with simulated sunlight before and after their introduction in emulsion formulations, demonstrated a relevant enhancement of the encapsulated sunscreen photostability in comparison with unencapsulated BMDBM.
2006
63
2
140
145
Influence of liposphere preparation on butyl-methoxydibenzoylmethane photostability / Iannuccelli, Valentina; Sala, Nicoletta; R., Tursilli; Coppi, Gilberto; S., Scalia. - In: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. - ISSN 0939-6411. - STAMPA. - 63:2(2006), pp. 140-145. [10.1016/j.ejpb.2006.01.007]
Iannuccelli, Valentina; Sala, Nicoletta; R., Tursilli; Coppi, Gilberto; S., Scalia
File in questo prodotto:
File Dimensione Formato  
European J. Pharm. Biopharm. 2006.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 350.59 kB
Formato Adobe PDF
350.59 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/304591
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 41
  • ???jsp.display-item.citation.isi??? 36
social impact